Bone marrow stem cell injections for knee arthritis are a treatment that uses stem cells from the body to improve the knee environment. They are popular with patients suffering from severe knee pain or seeking to slow the progression of arthritis.
By selectively selecting high-quality stem cells necessary for tissue regeneration and injecting them into the knee, therapeutic effects can be expected. The stem cell extraction system plays a crucial role in this process.
Most hospitals and clinics performing bone marrow stem cell injections use approved bone marrow processing devices. However, some medical device manufacturers have rebranded blood processing devices (PRP kits) as bone marrow processing devices, requiring caution.
According to Dr. Kebby of the Harvard University Institute for Immunological Diseases, “Bone marrow contains a population of nucleated cells at various stages of development.
These cells vary in density, but when PRP kits are used to isolate and concentrate bone marrow extracts, the nucleated cells essential for regeneration are virtually uncaptured.”
[Harvard University IDI Institute Results Letter]
In other words, the cell composition and density of blood and bone marrow differ, requiring the use of a dedicated kit tailored to the treatment. Otherwise, the absence of nucleated cells, which play a key role in regeneration, makes it difficult to expect effective treatment for knee arthritis.
To maximize the effectiveness of knee arthritis injections, it’s important to verify that both the stem cell extraction medical device and the bone marrow kit are approved for stem cell use.
It’s important to ensure that the device used has been validated by the Ministry of Food and Drug Safety for stem cell efficacy and that the correct dose of 10cc of concentrated cells, including stem cells, is injected.
Miracell’s SMART M-CELL has undergone an equivalence evaluation with the US-based SmartPrep stem cell extraction device.
In addition to receiving MFDS approval, the stem cell system has been recognized by the government for its superior stem cell extraction capabilities, earning it designation as a New Health Technology NET and an Innovative Product by the Public Procurement Service.
Intra-articular injection of bone marrow aspirate concentrate for knee osteoarthritis (Notice No. 2023-128, 918) was also directly registered by Miracell and recognized as a safe and effective new medical technology for treating knee joint pain and improving function.
[Edaily, Reporter Lee Soon-yong]
Source: https://www.edaily.co.kr/News/Read?newsId=03463686639016840&mediaCodeNo=257&OutLnkChk=Y